The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  January 2019 Next
  • EFMC Sponsorship rules and application forms can be found by clicking the  below links:

  • 26th Young Research Fellows Meeting

    February 20-22, 2019   Paris, France

    The YRFM Young Research Fellows Meeting is an initiative of the French Medicinal Chemistry Society (SCT). The 25th edition in Orleans gathered 250 young participants from Europe. The 26th edition will take place at the School of Pharmacy in Paris.
    This meeting brings together young European scientists (PhD students, post-doctoral fellows and young academic/industrial confirmed researchers) and gives them the opportunity to present and discuss the latest innovations and future trends in Medicinal Chemistry.
    The topics will cover all aspects of research in medicinal chemistry: the research and validation of biological targets of therapeutic interest, screening, design, optimization and selection of drug candidates, chemical biology, medicinal chemistry, pharmacokinetics, metabolism and toxicity (ADME-T: absorption, distribution, metabolism, excretion, toxicity).
    Many prestigious prizes will be attributed (SCT, ACS, EFMC) for best oral communications, and posters.

    Confirmed plenary lectures

    • Gilles Guichard (IECB, Bordeaux, France)
    • Fernanda Borges (School of Pharmacy, Porto, Portugal)
    • Gilles Pagès (IRCAN, Nice, France)
    • Emmanuel Mikros (School of Pharmacy, Athens, Greece)
    • Chantal Andraud (ENS, Lyon, France)
    Deadline for registration: December 20, 2018

    For more information contact

    Organised by : Société de Chimie Thérapeutique (France)

  • EUFEPS Annual Meeting 2019

    March 6-8, 2019   Frankfurt, Germany

    The aim of the Annual meeting is to bring together people from all over the world who are involved in pharmaceutical sciences in order to exchange results, experiences, and information and to build communication and collaboration at regional and global scales. Main target of the Annual Meeting 2019 is to create a pharmaceutical sciences platform between the university, industry and regulatory scientists in order to give a chance to discuss the main topics of this symposium in a friendly mood in an attractive environment of Frankfurt.

    This meeting will be focused on the theme “Personalized Medicines, Targeted Therapies and Precision Drug Delivery”. The main track of the meeting will continue throughout the scientific programme on March 6 to 8 covering basic and applied sciences on drug targets and drug formulation.

    As the concept of future medicines involves an extensive systems approach for both development and for pre-clinical and clinical evaluation, parallel tracks will be organized by networks and EUFEPS member institutions and societies to discuss different aspects.

    Deadline for abstract submission is January 10, 2019


  • 5th RSC-BMCS Symposium on Mastering Medicinal Chemistry

    March 13, 2019   Windlesham, United Kingdom

    Mastering Medicinal Chemistry V is the latest in an ongoing series of conferences intended to provide expert advice and guidance to new practitioners in the field of drug discovery.  It has been said that "there are two types of drug discovery programmes: those that hit serious problems and those that are going to hit serious problems". Anticipating and preparing for such problems thus accelerates the delivery of new medicines: this event will feature presentations from experienced 'drug-hunters' in both industry and academia, who will talk about the challenges faced in modern drug discovery, and will share the good practices common to all successful medicinal chemists.

    Confirmed Speakers:

    • Dr Kathleen Aertgeerts, Vertex Pharmaceuticals, United Kingdom
    • Prof Lennart Bunch, University of Copenhagen, Denmark
    • Dr Nicole Hamblin, Charles River, United Kingdom
    • Dr Christopher Johnson, Astex Pharmaceuticals, United Kingdom
    • Dr Lewis Vidler, Eli Lilly and Company, United Kingdom

    Bursary Application Deadline: Febraury 14, 2019

    Poster Abstract Deadline: Febraury 19, 2019

    Contact person: Mrs Maggi Churchouse
    Tel: +44 (0)1359 221004

  • Fragments 2019: 7th RSC-BMCS Fragment-Based Drug Discovery Meeting

    March 24-26, 2019   Cambridge, United Kingdom

    The aim of the 7th RSC-BMCS Fragment-based Drug Discovery meeting will be to continue the focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programmes. The Fragment series was started in 2007 and continues with the theme, having over three-quarters of the presentations focused on case studies. The conference will include successful examples from all types of fragment-based approaches, including high concentration, NMR, SPR and X-ray screening.


    • John Barker, Evotec, United Kingdom
    • Paul Brennan, Structural Genomics Consortium, University of Oxford, United Kingdom
    • Jacob Bush, GlaxoSmithKline, United Kingdom
    • Rob Cooke, Sosei Heptares, United Kingdom
    • Benjamin Cravatt, The Scripps Research Institute, United States
    • Harren Jhoti, Astex Pharmaceuticals, United Kingdom
    • Roderick Hubbard, University of York and Vernalis, United Kingdom
    • György M Keseru, Hungary Academy of Sciences, Hungary
    • Dirk Kessler, Boehringer Ingelheim, Austria
    • Andras Kotschy, Servier Research Institute of Medicinal Chemistry, France
    • Mauro Marigo, Lundbeck, Denmark
    • Darryl McConnell, Boehringer Ingelheim, Austria
    • Christian Ottmann, University of Eindhoven, Netherlands
    • Andreas Ritzén, LEO Pharma, Denmark
    • Payal Sheth, Merck, United States
    • Ed Tate, Imperial College London, United Kingdom
    • Alison Woolford, Astex Pharmaceuticals, United Kingdom
    • Yafeng Xue, AstraZeneca, United States

    Early Bird Registration Deadline: January 21, 2019

    Poster abstract and Bursary application deadline: February 1, 2019

    Standard Registration Deadline: February 22, 2019

    Contact person: Mrs Maggi Churchouse
    Tel: +44 (0)1359 221004

  • Integrin Targeted Drug Discovery

    March 28, 2019   London, United Kingdom

    Integrins are heterodimeric, transmembrane receptors that function in cell adhesion and signalling. They are central to many disease states, including cancer, thrombosis, multiple sclerosis and Crohn’s disease. Integrin targeted therapeutics have been under investigation for some time, but few compounds have made it to/ remained on the market due to side effects or lack of efficacy. Given the more recent structural insights, better understanding of downstream pathways, and potential application to a range of therapeutic areas, there has been a resurgence of interest in integrin inhibitors. This symposium will bring together researchers in this area to provide both a historical overview of the area and recent progress in designing the next generation of integrin inhibitors.


    • Dermot Cox, Royal College of Surgeons in Ireland, Ireland
    • Daria Giacomini, University of Bologna, Italy
    • Simon Goodman, Merck Serono, Germany
    • Horst Kessler, Technical University of Munich, Germany
    • Luciana Marinelli, University of Naples, Italy
    • Thomas McInally, University of Nottingham, United Kingdom
    • Kate Moore, Barts Cancer Institute, United Kingdom
    • Giovanna Musco, Ospedale San Raffaele, Italy
    • Helen Sheldrake, University of Bradford, United Kingdom

    Poster Abstract and Bursary Application Deadline: February 7, 2019

    Standard Registration Deadline: February 24, 2019

    Contact person: Mrs Maggi Churchouse
    Tel: +44 (0)1359 221004

  • 2nd Molecules Medicinal Chemistry Symposium - Facing Novel Challenges in Drug Discovery

    May 15-17, 2019   Barcelona, Spain

    The conference is organized by MDPI, the publisher of the open-access journal Molecules and follows the very successful one-day meeting,"Molecules Medicinal Chemistry Symposium (MMCS): Emerging Drug Discovery Approaches against Infectious Diseases", held in September 2017 at the School of Pharmacy and Food Sciences of the University of Barcelona, Spain, which turned out to be a very fruitful forum for discussion on the specific topic of anti-infective drug discovery, in an excellent atmosphere created by the more than 70 attendees from 20 countries.

    Encouraged by the great success of the initial small-format monographic MMCS2017, the three-day MMCS2019 will grow naturally by addressing a larger audience and essentially all topics of medicinal chemistry. The MMCS2019 will be organized into a number of thematic sessions on medicinal chemistry of particularly challenging diseases, novel and revisited drug discovery approaches, and medicinal chemistry stories about recently implemented projects in any area not covered in the other sessions, from target and hit identification to hit-to-lead optimization, tuning of physicochemical and pharmacokinetic properties, preclinical and clinical development, etc.

    Two prominent and inspiring keynote speakers per session will share the program with a number of selected oral communications, especially by young researchers. The program will be complemented by poster presentations, and social events on the second day of the conference.

    Keynote Speakers

    • Prof. Xavier Barril (University of Barcelona, Spain)
    • Prof. Dr Alessio Ciulli (University of Dundee, United Kingdom)
    • Prof. Dr Rebecca Deprez-Poulain (University of Lille, France)
    • Dr Eva Estébanez-Perpiñá (University of Barcelona, Spain)
    • Prof. Dr Christa E. Müller (University of Bonn, Germany)
    • Prof. Dr Stephen Neidle (University College London, United Kingdom)
    • Prof. Dr Barry V. L. Potter (University of Oxford, United Kingdom)
    • Prof. Dr Jörg Rademann (Free University of Berlin, Germany)
    • Prof. Dr Yi Sun (University of Michigan, United States and Zhejiang University, China)
    • Prof. Dr Santiago Vázquez (University of Barcelona, Spain)
    • Prof. Dr Mark von Itzstein (Griffith University, Australia)

    Deadline to submit your abstract is January 10, 2019

    Deadline for early bird registration is March 8, 2019

    Contact: George Andrianou

  • 11th Joint Meeting on Medicinal Chemistry

    June 27-30, 2019   Prague, Czech Republic

    In 2019, it will be 20 years of history of this traditional Joint Meetings, founded in 1999 by Prof. G. Ronsivalle (Italy) together with Prof. A. Lipkowski (Poland) and Prof. G. Toth (Hungary). On behalf of National Chemical Societies of Italy, Poland and Hungary, Prof G. Ronsivalle together with Prof. Z. Chilmonczyk (Poland) and Prof. P. Matyus (Hungary) organized the first meeting in Taormina in 1999, particularly to promote Medicinal Chemistry, attract young scientists and foster relationships between medicinal chemists of the participating countries. After Taormina, JMMC was held in Budapest 2001, Krakow 2003, Vienna 2005, Portorož 2007, Budapest 2009, Catania 2011, Lublin 2013, Athens 2015 and Dubrovnik 2017. Since the first meeting, number of participating countries has increased to nine – Austria, Croatia, Czech Republic, Greece, Hungary, Italy, Poland, Slovakia and Slovenia. The success of last 10th JMMC-2017 (249 participants from 28 countries) illustrates an interest of this kind of meetings. We are pleased to invite medicinal chemists from all over the world, not only participating countries, to come, stimulate discussion in drug discovery and development and to promote collaboration between medicinal chemistry scientists, both young and experienced.

    Confirmed Speakers

    • Dr. Tomas Cihlar (Gilead Sciences, United States)
    • Prof. Michal Hocek (Institute of Organic Chemistry and Biochemistry of the CAS, Czech Republic)
    • Assoc. Prof. Dr. Janez Ilas (University of Ljubljana, Slovenia)
    • Prof. Yoel Rodríguez (Hostos Community College of CUNY, United States)
    • Prof. Dr. Sanja Tomic (Ruder Boskovic Institute, Croatia)
    Deadline for abstract submission and early bird fee is March 1, 2019

    Contact person: Martin Dolezal
    Tel: +420495067389

  • Interfacing Chemical Biology and Drug Discovery (RICT 2019)

    July 3-5, 2019   Nantes, France

    The French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT) is pleased to invite you to Nantes, France on July 3-5, 2019 for the 55th edition of the International Conference on Medicinal Chemistry (RICT 2019).

    The congress will be devoted to “Interfacing Chemical Biology and Drug Discovery” and the main topics will be:

    • New Breakthroughs in Targeting PPIs
    • Recent Trends in Infectious Diseases Drug Development
    • Tackling New Challenges in Antibody-drug Conjugates
    • Inspired by Nature
    • Artificial Intelligence in Drug Discovery : Reality or Hype
    • Case studies: from target validation to novel drugs (all therapeutic areas included)

    As for previous editions of RICT, the scientific committee will ensure the high quality and diversity of the scientific programme together with the accessibility of the meeting to PhD/post-doc and local Master students. For the latter, an advantageous registration fee is proposed. Moreover, a special career session will be organised with industrial and academic participants.

    During the meeting, you will have the opportunity to listen to the recipient of the 2019 Paul Ehrlich Award and to the recipient of the Pierre Fabre Award for Therapeutic Innovation

    In addition, a poster session will provide the opportunity for all participants to present their current results. “Best poster” prizes will be attributed at the end of the meeting.

    For more information please contact:

    Organised by : Société de Chimie Thérapeutique (France)

31 01 02 03 04 05 06
07 08 09 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31 01 02 03
All events   |  Future events

Job portal

There are currently no jobs available

Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRocheSanofi
Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerckAstra ZenecaIdorsia